Characterization of Anti-Emicizumab Antibodies Using Repository Samples Obtained in Clinical Studies of Emicizumab Conducted in Japan

• Naoki Matsumoto,
• Hiroto Abe,
• Ryohei Kawasaki,
• Yoshihito Tashiro,
• Mariko Noguchi-Sasaki,
• Suguru Harada,
• Koichiro Yoneyama,
• Tomomi Niino,
• Tetsuhiro Soeda,
• Yasushi Yoshimura

Affiliations

Naoki Matsumoto

ORCiD

Chugai Pharmaceutical Co., Ltd., Yokohama, Kanagawa, Japan

Hiroto Abe

Chugai Pharmaceutical Co., Ltd., Yokohama, Kanagawa, Japan

Ryohei Kawasaki

Chugai Pharmaceutical Co., Ltd., Yokohama, Kanagawa, Japan

Yoshihito Tashiro

Chugai Pharmaceutical Co., Ltd., Yokohama, Kanagawa, Japan

Mariko Noguchi-Sasaki

ORCiD

Chugai Pharmaceutical Co., Ltd., Yokohama, Kanagawa, Japan

Suguru Harada

Chugai Pharmaceutical Co., Ltd., Yokohama, Kanagawa, Japan

Koichiro Yoneyama

Chugai Pharmaceutical Co., Ltd., Chuo-ku, Tokyo, Japan

Tomomi Niino

Chugai Pharmaceutical Co., Ltd., Chuo-ku, Tokyo, Japan

Tetsuhiro Soeda

Chugai Pharmaceutical Co., Ltd., Yokohama, Kanagawa, Japan

Yasushi Yoshimura

Chugai Pharmaceutical Co., Ltd., Yokohama, Kanagawa, Japan